STOCK TITAN

Retrieve Medical Holdings Inc Stock Price, News & Analysis

RMHI OTC

Welcome to our dedicated page for Retrieve Medical Holdings news (Ticker: rmhi), a resource for investors and traders seeking the latest updates and insights on Retrieve Medical Holdings stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Retrieve Medical Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Retrieve Medical Holdings's position in the market.

Rhea-AI Summary

Retrieve Medical (OTC: RMHI) announced the commercial launch of Retrieve Passport, a consumer-facing platform that gives individuals portable, secure access to their complete medical records worldwide. The company said it is entering commercial production after development, regulatory alignment, interoperability integration, and security validation. Key features include a physical MyRetrieve Passport card with a secure QR code, consolidation of records via a nationwide health information exchange, and real-time translation of medical summaries. Commercial rollout begins immediately with expanded availability planned through 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Retrieve Medical Holdings (OTC:RMHI) has announced a partnership with ID.me to power secure sign-in and identity verification for its upcoming platform, Retrieve Personal. The platform will provide instant access to complete medical records through integration with Health Information Exchanges (HIEs) and major health networks.

The platform leverages advanced AI to organize medical information including diagnoses, medications, allergies, lab results, and procedures into actionable summaries. Retrieve Personal will offer a secure credit card-sized format allowing patients to instantly access their verified health records at points of care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.09%
Tags
none
-
Rhea-AI Summary

Retrieve Medical Holdings (OTC: RMHI) and MyID have announced a joint venture to launch the first-ever wearable device with integrated Electronic Health Records (EHR). The groundbreaking platform combines Retrieve Medical's AI technology with MyID's smart wearables to provide users with real-time, provider-verified health profiles accessible worldwide.

The system uniquely connects to Health Information Exchanges (HIEs), aggregating live medical records across providers using advanced natural language processing. MyID currently serves over 314,000 medical profile users, up from 302,000 in late 2024. The first product is set to launch in Q3 2025, followed by a national retail rollout. The company has ended discussions with Curatus to focus on this venture.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Retrieve Medical Holdings (OTC Pink: RMHI) has secured its second U.S. patent (No. 12,272,437 B2) for 'Creating and Updating Problem Lists for Electronic Health Records.' The patent, issued on April 8, 2025, enhances the company's intellectual property portfolio in EHR system management.

The technology introduces key advancements including:

  • Real-time synchronization using natural language processing (NLP) for automatic updates
  • Duplicate entry prevention through NLP algorithms
  • Role-based access control for data privacy
  • Optimized data transmission system for efficient network usage

The innovation focuses on improving problem list management in EHR systems, which are important documents containing patients' active and past health conditions. The system aims to enhance clinical accuracy and reduce administrative burden in healthcare settings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Retrieve Medical Holdings (OTC Pink: RMHI) has emphasized its commitment to compliance amid increased scrutiny of Medicare Advantage billing practices. The company's patent-pending Retrieve Dx technology acts as a virtual research assistant, presenting potential diagnoses from patient records before physician finalization.

The announcement comes as Medicare Advantage programs, representing $462 billion (54%) of federal Medicare spending and serving 32.8 million beneficiaries across 3,500 plans, face intense scrutiny. Retrieve's preprocessing technology ensures accurate diagnosis submissions by integrating research assistant functions without disrupting clinical workflow.

Unlike systems that use AI to retroactively add diagnoses, Retrieve Dx operates prospectively, supporting accurate coding from the outset while maintaining physician control over the CDI process. The company emphasizes that its approach prevents False Claims Act violations by avoiding unsupported diagnosis additions through template addenda forms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
none
-
Rhea-AI Summary

Retrieve Medical Holdings has signed a Letter of Intent to acquire Cúratus , a Nevada-based technology company specializing in AI-driven provider data solutions. The acquisition will integrate Cúratus' SaaS platform, ProviderLenz, into Retrieve's healthcare solutions network.

The deal is subject to definitive agreement, closing conditions, public filings, and shareholder approval. Mark Fabiano, Cúratus' CEO and former Chief Sales Officer at Altegra Health, will continue leading the company as a subsidiary of Retrieve Medical Holdings.

ProviderLenz uses AI to aggregate and verify provider credentialing and directory data in real-time, addressing a critical issue in healthcare where credentialing errors and fraud contribute to over $100 billion in annual healthcare fraud costs. The merger aims to enhance operational efficiency, improve decision-making, and optimize patient care through advanced AI capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
56.9%
Tags
Rhea-AI Summary

Retrieve Medical has announced its expansion into ambulatory care through a new partnership with Saint Joseph's Medical Center in Yonkers, New York. The 333-bed health system will implement Retrieve's AI-powered software in its busiest multi-specialty physician practice.

The software has been specifically enhanced for outpatient settings, focusing on chronic condition detection and management. This implementation aligns with value-based healthcare models, aiming to improve patient outcomes and increase reimbursement potential.

According to Mark Rosenberg, Chairman of Retrieve and Past President of the American College of Emergency Physicians, chronic condition identification is important for value-based care, impacting both patient wellness and financial sustainability. Saint Joseph's Medical Center, established in 1888, continues its commitment to innovation and excellence in healthcare management through this partnership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
85.19%
Tags
none
-
Rhea-AI Summary

Onpoint Healthcare Partners and Retrieve Medical have announced the successful integration of their healthcare technology solution, combining Retrieve Medical's AI-powered engine with Onpoint's Iris platform. The integrated solution is being launched at two sites with over 850 healthcare providers.

The implementation aims to enhance clinical workflows, reduce administrative burdens, and improve patient outcomes. Key benefits include improved documentation efficiency with a 50% decrease in administrative overload, enhanced chronic disease management through identification and management of conditions in patient records, and reduction in provider burnout.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary

Retrieve Medical and OnPoint Healthcare Partners have announced a groundbreaking technology partnership to integrate Retrieve Medical's AI-powered engine into OnPoint's IRIS platform. This collaboration aims to revolutionize healthcare technology by enhancing clinical documentation and data processing capabilities.

The integration is expected to significantly improve healthcare efficiency, potentially reducing patient visit times by up to 50% and allowing physicians to manage complex disease state data more effectively. This partnership is set to address the growing administrative burden on healthcare providers, combat burnout, and improve patient care quality.

The combined technologies will excel in identifying and managing chronic conditions, providing healthcare professionals with more accurate and timely patient health insights. This advancement is poised to set new standards in healthcare technology, moving towards a more efficient and patient-centric healthcare system.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
Rhea-AI Summary

Retrieve Medical Holdings announced a new patent aimed at improving problem list management within electronic health records (EHR) systems. The patent introduces a hierarchical structure to problem lists, allowing designated managers to control and oversee entries and modifications. Key features include segmentation by department or interest area, master problem list management by primary care physicians, and individual provider lists that integrate into the master list. This innovation aims to enhance control, visibility, and accuracy in patient data management, ultimately helping healthcare providers deliver higher-quality care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Retrieve Medical Holdings (rmhi)?

The current stock price of Retrieve Medical Holdings (rmhi) is $2.35 as of February 23, 2026.

What is the market cap of Retrieve Medical Holdings (rmhi)?

The market cap of Retrieve Medical Holdings (rmhi) is approximately 27.6M.

RMHI Rankings

RMHI Stock Data

27.55M
20.83M
Health Information Services
Healthcare
Link
United States
Bedminster

RMHI RSS Feed